Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 848.4 Million | USD 1695.97 Million | 8% | 2023 |
The global Gastrointestinal Bleeding Treatment Market size was worth around USD 848.4 million in 2023 and is predicted to grow to around USD 1695.97 million by 2032 with a compound annual growth rate (CAGR) of roughly 8.00% between 2024 and 2032.
The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD million). The report covers a forecast and an analysis of the Gastrointestinal Bleeding Treatment Market on a global and regional level.
Gastrointestinal (GI) bleeding is the bleeding of digestive tracts and is an extremely serious symptom that occurs within the digestive organs like esophagus, stomach, small intestine including the duodenum, rectum, etc. There are two types of GI bleeding, upper and lower. If the bleeding occurs in the stomach that is the initial part of small intestine or in esophagus, it is known as the upper GI bleeding, whereas if bleeding occurs in rectum or initial part of the large intestine then it is called lower GI bleeding. There are various factors responsible for gastrointestinal bleeding. Among them, ulcers are the most common factor affecting the upper GI tract. Fluid resuscitation and airway management are some options for gastrointestinal bleeding treatment.
The gastrointestinal bleeding treatment market is growing due to the rising endoscopic hemostasis demand and increasing geriatric population base. The population suffering from gastrointestinal bleeding majorly affects the age group above 85 years, as per the U.S. National Library of Medicine National Institutes of Health. The problem among the aging population is an epidemiological phenomenon and gastrointestinal bleeding is a growing problem, requiring solution in everyday clinical practice. Additionally, the growth in the use of endoscopic hemostasis, strategic mergers and acquisitions by key market players, new product launch, and funding from government and non-government bodies for research to spread awareness regarding gastrointestinal bleeding treatment has further propelled the market growth.
The study provides a decisive view of the gastrointestinal bleeding treatment market by segmenting it based on product, GI tract division, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.
By product, the gastrointestinal bleeding treatment market includes thermal devices, endoscopic hemostatic devices, mechanical device, closure devices, and others.
On the basis of GI tract division, the market includes lower and upper.
By end-user, the market for gastrointestinal bleeding treatment comprises hospitals, clinics, ambulatory surgical centers, and others.
Report Attributes | Report Details |
---|---|
Report Name | Gastrointestinal Bleeding Treatment Market |
Market Size in 2023 | USD 848.4 Million |
Market Forecast in 2032 | USD 1695.97 Million |
Growth Rate | CAGR of 8% |
Number of Pages | 130 |
Key Companies Covered | Erbe Elektromedizin, CONMED Corporation, Ovesco Endoscopy, U.S. Medical Innovations, and Boston Scientific Corporation |
Segments Covered | By Product, By GI Tract Division and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
North America and Europe are anticipated to account for major shares in the gastrointestinal bleeding treatment market globally in the years ahead. The Asia Pacific gastrointestinal bleeding treatment market is expected to register a high rate of growth in the future. There has been a sharp rise in the occurrences of various cardiovascular diseases along with the growing aging population that is accelerating the gastrointestinal bleeding treatment market growth in this region.
Some key players operating in the gastrointestinal bleeding treatment market are:
Global Gastrointestinal Bleeding Treatment Market: Product Analysis
Global Gastrointestinal Bleeding Treatment Market: GI Tract Division Analysis
Global Gastrointestinal Bleeding Treatment Market: End-User Analysis
Global Gastrointestinal Bleeding Treatment Market: Regional Analysis
FrequentlyAsked Questions
Gastrointestinal (GI) bleeding is the bleeding of digestive tracts and is an extremely serious symptom that occurs within the digestive organs like esophagus, stomach, small intestine including the duodenum, rectum, etc.
According to study, the Gastrointestinal Bleeding Treatment Market size was worth around USD 848.4 million in 2023 and is predicted to grow to around USD 1695.97 million by 2032.
The CAGR value of Gastrointestinal Bleeding Treatment Market is expected to be around 8.00% during 2024-2032.
North America and Europe has been leading the Gastrointestinal Bleeding Treatment Market and is anticipated to continue on the dominant position in the years to come.
The Gastrointestinal Bleeding Treatment Market is led by players like Erbe Elektromedizin, CONMED Corporation, Ovesco Endoscopy, U.S. Medical Innovations, and Boston Scientific Corporation.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed